Who is sponsoring NCT01968252?

NCT01968252 is sponsored by University of Nebraska.

What drugs are being tested in NCT01968252?

Interventions in NCT01968252: Concurrent TTE and TEE.

What condition does NCT01968252 study?

NCT01968252 studies Ventricular Function, Right.

Is NCT01968252 still recruiting?

NCT01968252 is currently completed. Last updated 1 September 2023.

Last reviewed 2023-09-01 · How we verify

NCT01968252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Speckle-tracking Tricuspid Annular Plane Systolic Excursion

Completed Last updated 1 September 2023

What this trial tests

trial testing Concurrent TTE and TEE in Ventricular Function, Right in 112 participants. Completed in 1 November 2015.

Timeline

1 May 2014

Primary endpoint
1 February 2015

1 November 2015

Quick facts

Lead sponsor	University of Nebraska
Status	Completed
Study type	OBSERVATIONAL
Enrollment	112
Start date	1 May 2014
Primary completion	1 February 2015
Estimated completion	1 November 2015
Sites	1 location across United States

Drugs / interventions tested

Concurrent TTE and TEE

Conditions studied

Ventricular Function, Right — all drugs for Ventricular Function, Right →

Sponsor

University of Nebraska

Who can join

Adults 19 to 90, any sex, with Ventricular Function, Right. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to validate the use of speckle-tracking echocardiography to measure tricuspid annular plane systolic excursion as a measurement of right ventricular function during transesophageal echocardiography.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Nebraska trials

Trials by the same sponsor.

NCT07507006 — Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance · NA · not yet recruiting
NCT07517705 — MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma · NA · not yet recruiting
NCT07506993 — Inflammation in Clear Aligners With and Without Attachments · not yet recruiting
NCT07207850 — Parents Helping Parents for Youth Vaping Cessation · NA · not yet recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01968252 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Nebraska
Last refreshed: 1 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01968252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing